System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Tatjana S Potpara, MD, PhD, FESC

Cardiology — Klinički centar Srbije, Serbia

LeadR Profile

Tatjana S Potpara, MD, PhD, FESC Klinički centar Srbije Serbia
1 429 ScienceLeadR Reputation 1429

Unlock

Register Login
Network Map

Cardiology

Subspecialties: Hematology - Pharmacy - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1993 - 2026
Source: PubMed

University of Belgrade

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 429

Citations

Citations: 36 536 1st author: 84 Last author: 81 Unique author: 6

Main journals

Europace 117
Eur Heart J 48
Thromb Haemost 16
Kardiol Pol 12
Eur J Intern Med 11

Best Journals

Eur Heart J 21
N Engl J Med 3
Nat Rev Cardiol 2

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Clinical Event Rates and Patient Satisfaction with Generic Rivaroxaban in Atrial Fibrillation: The Prospective Guardian Study.
diabetes mellitus, anticoagulants, hemorrhage, stroke, rivaroxaban, atrial fibrillation, therapeutics, history, patient satisfaction, direct-acting oral anticoagulants		TH Open20260
Integrated care management and comprehensive geriatric assessment using a mHealth-based approach in older multimorbid patients with atrial fibrillation: the AFFIRMO cluster-randomised trial.
atrial fibrillation, geriatric assessment		Lancet Reg Health Eur20260
Patient Self-Reported Global Satisfaction With Rivaroxaban in Patients With Atrial Fibrillation: A Comparison Between Oral Anticoagulation-Naïve Versus Oral Anticoagulation-Experienced Patients.
anticoagulants, rivaroxaban, atrial fibrillation, cardiology, therapeutics, patient satisfaction, direct-acting oral anticoagulants		Clin Cardiol20260
ISN International Expert Forum: Exploring the Nexus of Cardiovascular-Kidney-Metabolic (CKM) Health.
diabetes mellitus, kidney diseases, cardiovascular diseases, kidney, obesity, therapeutics		Kidney Int20261
Quality of life, care needs and priorities in atrial fibrillation: the impact of number and patterns of comorbidities.
diabetes mellitus, quality of life, comorbidity, pain, caregivers, rehabilitation, kidney, atrial fibrillation, liver, multimorbidity, therapeutics		Qual Life Res20260

Clinical Studies 6

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 3 3
N/A 2
Phase 4 1

By status:

Completed 3
Active not recruiting 2
Recruiting 1

By type:

Interventional 6

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 0
multicentric5to9 0
multicentricup10 6

Main Topics

Cohort/Consortium Investigators 6

Ongoing Clinical Trials

3 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Integrated Approach in Frail Older People with Atrial Fibrillation
NCT06775028 — diabetes mellitus, exercise, hypertension, stroke, ischemic attack, transient, heart failure, pharmaceutical preparations, heart, atrial fibrillation, diet, pulmonary disease, chronic obstructive, vascular diseases, peripheral vascular diseases, peripheral arterial disease, therapeutics		N/ARecruiting2024
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
NCT05757869 — safety, atrial fibrillation, factor xia, apixaban, factor xia inhibitor		Phase 3Active not recruiting2023
Stroke Prevention and Rhythm Control Therapy STEEER AF
NCT04396418 — guideline adherence, stroke, atrial fibrillation, cardiology, therapeutics, education, random allocation		N/AActive not recruiting2021

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS